CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 57 enrolled
Drug / intervention
Vitamin D3dietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01667796
NCT01667796N/ACompleted
CompareCT.gov

Pharmacodynamic and Immunologic Effects of Vitamin D Supplementation in Patients With Multiple Sclerosis and Healthy Controls

Johns Hopkins University·interventional·Posted Aug 17, 2012·Updated Mar 5, 2019

In Brief

A clinical study evaluating Vitamin D3 for Multiple Sclerosis, Relapsing-remitting. Completed, enrolled 57 participants across 2 sites.

Detailed Summary

This is a pilot study of oral vitamin D supplementation to determine if patients with Multiple Sclerosis (MS) and healthy individuals attain a similar increase in serum 25-hydroxyvitamin D levels. The investigators will also assess whether the immunologic or relevant gene expression response to oral vitamin D supplementation differs in patients with MS and healthy controls.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMultiple Sclerosis, Relapsing-remitting
CountriesUnited States
CollaboratorsUniversity of California, San Francisco, National Multiple Sclerosis Society

Timeline

N/ACompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
First PostedAug 17, 2012
Enrollment StartNov 1, 2010
Primary CompletionMar 1, 2014
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 13.9 years ago

Interventions

Vitamin D3dietary